Light-Triggered Structural Changes in Biologics
Light-Triggered Structural Changes in Biologics Understanding Light-Induced Structural Changes in Biologics: Risks and Mitigation Biologic drug products—including monoclonal antibodies, peptides, and recombinant proteins—are complex molecules susceptible to structural modifications upon exposure to light. These changes can compromise product efficacy, trigger immunogenic responses, and lead to regulatory challenges. This guide outlines the mechanisms by which light…
Read More “Light-Triggered Structural Changes in Biologics” »